DAYTONA BEACH, Fla. -- NASCAR announced today that it is teaming up with Janssen Pharmaceuticals, Inc., to help make a difference for racing fans who are at risk for or are living with blood clots. Janssen, the maker of XARELTO? (rivaroxaban), an important medicine used to treat and help prevent blood clots, is now the Official Cardiovascular Partner of NASCAR. "We are encouraged to see Janssen Pharmaceuticals' level of dedication to helping fans affected by blood clots," said Jim O'Connell, NASCAR chief sales officer. "We welcome them to the NASCAR family, not only as an Official Partner but also as a race entitlement and team sponsor." More...